CAMP4 Therapeutics Corporation (CAMP) Return on equity 2024–2025
CAMP4 Therapeutics Corporation (CAMP) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-168.5%FY2025 · since FY2024: -82.0% → -168.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -168.5% | -86.5 pp |
| FY2024 | -82.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More CAMP financial trends
CAMP RevenueCAMP Net incomeCAMP Net marginCAMP Gross profitCAMP Gross marginCAMP Operating incomeCAMP Operating marginCAMP Operating cash flowCAMP Free cash flowCAMP Capital expendituresCAMP Stock buybacksCAMP Dividends paidCAMP Total assetsCAMP Total liabilitiesCAMP Shareholders’ equityCAMP overview →